Suchergebnisse - "de Vries, E"

PubPharm (1.378)

1

Infections in biological and targeted synthetic drug use in rheumatoid arthritis: where do we stand? A scoping review and meta-analysis

enthalten in: bioRxiv.org | 2024

von Bergmans, B. | Gebeyehu, B. | van Puijenbroek, E. | +4

2

Prediction model for lower limb amputation in hospitalized diabetic foot patients using classification and regression trees

enthalten in: Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons | 2024

von Sánchez, C. | De Vries, E. | Gil, F. | +1

3

Using administrative registries as a source for population-based cancer incidence and mortality

enthalten in: BMC cancer | 2024

von Corredor, C. | Piñeros, M. | Wiesner, C. | +1

CommentOn: BMC Cancer. 2020 Nov 11;20(1):1097. - PMID 33176754

4

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Kiesewetter, B. | Dafni, U. | de Vries, E. | +21

5

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors

enthalten in: ESMO open | 2023

von Oosting, S. | van der Veldt, A. | Fehrmann, R. | +20

6

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Oosting, S. | Barriuso, J. | Bottomley, A. | +13

7

Off-label despite high-level evidence : a clinical practice review of commonly used off-patent cancer medicines

enthalten in: ESMO open | 2023

von Zarkavelis, G. | Amylidi, A. | Verbaanderd, C. | +14

8

Defining vulnerability subgroups among pregnant women using pre-pregnancy information : a latent class analysis

enthalten in: European journal of public health | 2023

von Molenaar, J. | van der Meer, L. | Bertens, L. | +6

9

Off-label despite high-level evidence : a clinical practice review of commonly used off-patent cancer medicines

enthalten in: ESMO open | February 2023

von Zarkavelis, G. | Amylidi, A. | Verbaanderd, C. | +14

10

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

enthalten in: ESMO open | 2023

von van der Veldt, A. | Oosting, S. | Fehrmann, R. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[138]